Protonix Granule, Delayed Release
Product Images NDC 0008-0844

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Protonix (NDC 0008-0844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Protonix 01)

FDA Label Image

Logo (Protonix 02)

Logo (Protonix 02)
This is a label of a pharmaceutical product distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. headquartered in Philadelphia, PA 19101.*
FDA Label Image

Protonix 02a

Protonix 02a
This is a medication from Pfizer that is distributed through its subsidiary Wyeth Pharmaceuticals LLC based in Philadelphia, PA 19101.*
FDA Label Image

Logo (Protonix 03)

Logo (Protonix 03)
This is a product label or package distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The company is located in Philadelphia, PA 19101.*
FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Principal Display Panel (20 mg Tablet Bottle Label)
This seems to be a description of a medication named "Pantoprazole" in the form of delayed-release tablets. Each tablet contains 20mg of Pantoprazole or equivalent to 22.56 mg of Pantoprazole sodium. It is recommended to swallow the tablet as a whole and not to split, chew or crush it. The usual dosage is not available, but it is advised to store the medication between 20°-25°C (68°-77°F), and excursions are permitted to 15°-30°C (50°-86°F).*
FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Principal Display Panel (40 mg Tablet Bottle Label)
This appears to be a medication guide for Pantoprazole sodium, delayed-release tablets with a 40mg dosage of Pantoprazole. The guide includes instructions to swallow the tablet whole and not split, chew, or crush it. It also includes information on storage conditions. The rest of the text is not legible due to errors.*
FDA Label Image

Principal Display Panel (40 mg Granule Packet)

Principal Display Panel (40 mg Granule Packet)
This is a description of a medication, called Pantoprazole sodium, in delayed-release oral suspension form. Each packet contains 40mg of Pantoprazole (equivalent to 45.1 mg of Pantoprazole sodium) and should only be taken in suspension with apple juice or applesauce. The medicinal product is by Protonix and only available as a prescription. The remaining text is not available due to errors.*
FDA Label Image

Principal Display Panel (40 mg Granule Packet Carton)

Principal Display Panel (40 mg Granule Packet Carton)
Protonix is a medication available in the form of delayed-release Oral Suspension. The medication comes in packets and each packet contains Pantoprazole Sodium, which is equivalent to 45.1 mg of pantoprazole at 40 mg concentration. The medicine should always be dispensed with a medication guide. The medication can be administered with applesauce or apple juice only after stirring. Protonix should not be crushed or chewed and should be taken 30 minutes before a meal. The complete direction of use and dosing instructions can be obtained from the package insert. Keep the medication out of reach of children, and store it at 68° to 77°F, with excursions permitted to 59° to 86°F. The manufacturer of the medicine is Wyeth Pharmaceuticals sold under license from Takeda GmbH, Germany.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.